Exelixis Clinical Site #164
Mainz, Rhineland-Palatinate 55131
0 studies enrolling now · 1 studies all time
What they study most
Renal Cell Carcinoma
Studies at this site
Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma
— Running, not enrolling